EarningsQ3 2020 Earnings Report

Galectin Therapeutics (PHPN) Q3 2020 Earnings Report

0 Followers

DE:PHPN Q3 2020 EPS Results

Actual EPS-€0.09

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€0.04

Actual Revenue€0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ3 2020

Date11/09/2020

TimeBefore Open

Conference CallMonday, November 9, 2020

DE:PHPN Upcoming Earnings

Galectin Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 16, 2026	2026 (Q3)	-0.04 / -	-0.113	―
Aug 14, 2026	2026 (Q2)	-0.08 / -0.12	-0.105	-16.67% (-0.02)
May 15, 2026	2026 (Q1)	- / -0.07	-0.131	46.67% (+0.06)
Mar 31, 2026	2025 (Q4)	-0.05 / -0.07	-0.131	46.67% (+0.06)
Nov 14, 2025	2025 (Q3)	-0.10 / -0.11	-0.157	27.78% (+0.04)
Aug 14, 2025	2025 (Q2)	-0.14 / -0.10	-0.174	40.00% (+0.07)
May 15, 2025	2025 (Q1)	- / -0.13	-0.165	21.05% (+0.03)
Mar 31, 2025	2024 (Q4)	-0.17 / -0.13	-0.165	21.05% (+0.03)
Nov 14, 2024	2024 (Q3)	-0.17 / -0.16	-0.209	25.00% (+0.05)
Aug 13, 2024	2024 (Q2)	-0.14 / -0.17	-0.131	-33.33% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed